NTLA short interest
Intellia Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 45,110,513 |
|---|---|
| Change vs prior report | -1,571,096 (-3.4%) |
| Change over six months | +15.8% |
| Days to cover | 9.47 (sector: 3.78) |
| Average daily volume | 4,765,594 |
| Rank in Healthcare | #127 of 922 by days to cover |
NTLA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 45,110,513 | -3.4% | 9.47 | 4,765,594 |
| 2026-09-15 | 46,681,609 | +6.3% | 14.10 | 3,311,168 |
| 2026-08-31 | 43,928,014 | -2.1% | 12.89 | 3,408,436 |
| 2026-08-14 | 44,880,339 | +2.0% | 13.15 | 3,412,934 |
| 2026-07-31 | 44,010,769 | -3.9% | 11.96 | 3,680,746 |
| 2026-07-15 | 45,776,294 | -7.0% | 9.75 | 4,694,333 |
| 2026-06-30 | 49,218,272 | -2.2% | 7.54 | 6,528,309 |
| 2026-06-15 | 50,318,535 | +3.7% | 7.46 | 6,743,092 |
| 2026-05-29 | 48,516,271 | -6.4% | 9.23 | 5,256,351 |
| 2026-05-15 | 51,849,425 | +19.1% | 7.68 | 6,755,199 |
| 2026-04-30 | 43,531,487 | +12.2% | 4.31 | 10,094,389 |
| 2026-04-15 | 38,812,013 | -0.3% | 15.42 | 2,517,006 |
| 2026-03-31 | 38,945,982 | -1.2% | 10.84 | 3,592,807 |
| 2026-03-13 | 39,439,406 | -11.0% | 7.66 | 5,147,599 |
| 2026-02-27 | 44,306,166 | -2.1% | 17.28 | 2,563,308 |
| 2026-02-13 | 45,259,873 | -0.1% | 11.92 | 3,797,415 |
| 2026-01-30 | 45,319,683 | +6.5% | 5.69 | 7,963,739 |
| 2026-01-15 | 42,557,725 | +2.4% | 7.53 | 5,648,605 |
| 2025-12-31 | 41,565,401 | +2.4% | 13.73 | 3,028,294 |
| 2025-12-15 | 40,578,361 | -9.0% | 10.40 | 3,900,390 |
| 2025-11-28 | 44,572,813 | +10.8% | 9.48 | 4,701,402 |
| 2025-11-14 | 40,235,935 | +3.0% | 4.13 | 9,751,398 |
| 2025-10-31 | 39,075,621 | +26.4% | 3.20 | 12,205,395 |
| 2025-10-15 | 30,904,192 | +3.9% | 4.20 | 7,353,538 |
| 2025-09-30 | 29,739,035 | -12.9% | 3.64 | 8,171,291 |
import finzdata as yf
yf.Ticker("NTLA").short_interest # every report since 2017
yf.Client().short_interest(["NTLA"], start="2018-01-01")Healthcare short interest · NTLA price history · Who owns NTLA · All short interest